Pathogenetic treatment of patients with new coronavirus infection COVID-19

L. Shovkun (Rostov-on-Don, Russian Federation), D. Kudlay (Moscow, Russian Federation), N. Nikolenko (Moscow, Russian Federation), E. Kampos (Rostov-on-Don, Russian Federation)

Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors
Session: COVID – 19: treatments and predictive factors
Session type: E-poster
Number: 801

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Shovkun (Rostov-on-Don, Russian Federation), D. Kudlay (Moscow, Russian Federation), N. Nikolenko (Moscow, Russian Federation), E. Kampos (Rostov-on-Don, Russian Federation). Pathogenetic treatment of patients with new coronavirus infection COVID-19. 801

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Respiratory viral sepsis: epidemiology, pathophysiology, diagnosis and treatment
Source: Eur Respir Rev, 29 (157) 200038; 10.1183/16000617.0038-2020
Year: 2020



Prevalence of virus infections in patients with asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 599s
Year: 2004

Update on management of new emerging acute respiratory viral infectious diseases
Source: International Congress 2018 – Chinese Programme 2018: Part I
Year: 2018


Features of the clinical course of coronavirus and bacterial pneumonia
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021


Pathomechanisms mediating bacterial co-infection following respiratory viral disease
Source: Lung Science Conference 2015
Year: 2015




Evaluation of efficacy of interferon inducer in treatment of the recurrent acute respiratory viral infections in children
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012


Clinical diagnosis of influenza infection in children
Source: Eur Respir J 2002; 20: Suppl. 38, 336s
Year: 2002

Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients
Source: Eur Respir J 2002; 20: 28S-39S
Year: 2002



Prevention and treatment of viral infections: CMV and other community respiratory viruses
Source: ERS Course 2016
Year: 2016



Historical perspective: other human coronavirus infectious diseases, SARS and MERS
Source: Eur Respir Monogr 2021; 94: 28-38
Year: 2021


Clinical feature of 4 cases of severe pneumonia in pregnant women with influenza A(H1N1) virus infection
Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis
Year: 2010


The role of viral and bacterial infections in asthma severity
Source: Annual Congress 2005 - PG3 - Asthma: natural history, risk factors and overall management
Year: 2005

The role of respiratory viruses in etiological structure of exacerbation of chronic and recurrent lung diseases in children
Source: Eur Respir J 2007; 30: Suppl. 51, 391s
Year: 2007

The immunology of virus infection in asthma
Source: Eur Respir J 2001; 18: 1013-1025
Year: 2001



Clinical and virusological effectiveness study of ultralow doses of antibodies to interferon-gamma in treatment of acute respiratory viral infections and influenza in children
Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood
Year: 2009

Secondary pulmonary mycoses etiology agent species diversity in patients with tuberculosis and in patients with HIV infection
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020


Spectrum of viral pathogens in adult patients with infectious exacerbation of chronic bronchitis
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016


Short-term survival of acute respiratory distress syndrome patients due to influenza virus infection alone: a cohort study
Source: ERJ Open Res, 6 (4) 00587-2020; 10.1183/23120541.00587-2020
Year: 2020



Prevalence of hepatitis c virus infection among patients with COPD
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009